EGFR/B7H3 CAR-T on Lung Cancer and Triple Negative Breast Cancer

Clinical trial NCT05341492 · RECRUITING

Trial details

NCT number: NCT05341492
Sponsor: Second Affiliated Hospital of Guangzhou Medical University
Status: RECRUITING
Phase: Early Phase 1
Study type: INTERVENTIONAL

EGFR/ B7H3-positive Advanced Lung Cancer EGFR/ B7H3-positive Advanced Triple-negative Breast Cancer

Start date: 2022-05-01
Primary completion: 2030-05-01
Enrollment: 30

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.